Biosearch Technologies represents genomic tools for mission critical customer applications
Investment follows other acquisitions in oligonucleotide reagent and synthesised oligonucleotides markets
Replaces Dr Derek Craston, who completed two terms of five years each in this Office
Announcement a further strengthening of nucleic acid chemistry (NAC)
Lucigen offers extensive enzymology expertise and a wide portfolio of molecular biology reagents
Will benefit customers of LGC and NuGEN, as it expands options to access SPET technology through SeqSNP service
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.